NSE - Delayed Quote INR

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

1,687.80
+0.40
+(0.02%)
At close: June 13 at 3:29:58 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Dilip Shantilal Shanghvi MD & Chairman of the Board 60.54M -- 1955
Mr. Aalok Dilip Shanghvi COO, Head of Global Generics R&D, Business Devp., and Whole Time Director 68.75M -- 1984
Mr. C. S. Muralidharan ICWA, M.Com Chief Financial Officer 38.89M -- 1963
Mr. Dheeraj Prasad Sinha BE EVP & Chief Information Officer -- -- 1971
Dr. Abhishek Sharma VP, Head of Investor Relations & Strategic Projects -- -- --
Mr. Anoop Deshpande Company Secretary & Compliance Officer -- -- --
Mr. Kalyanasundaram Subramanian Director of Corporate Development 65.3M -- 1954
Mr. Suresh Kumar Rai Chief Human Resources Officer -- -- --
Mr. Kirti Wardhaman Ganorkar Head of India Business -- -- 1967
Mr. Abhay Gandhi Chief Executive Officer of North America Business -- -- 1965

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai, 400063
India
91 22 4324 4324 https://www.sunpharma.com
Sector: 
Healthcare

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.

Corporate Governance

Sun Pharmaceutical Industries Limited’s ISS Governance QualityScore as of June 1, 2025 is 4. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 6; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 4, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 30, 2025 at 10:59 AM UTC - August 4, 2025 at 12:00 PM UTC

Sun Pharmaceutical Industries Limited Earnings Date

Recent Events

Related Tickers

CIPLA.NS Cipla Limited
1,505.20
+0.16%
 
LUPIN.NS Lupin Limited
1,999.60
-1.17%
 
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,362.50
-0.01%
 
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,669.90
+1.85%
 
AUROPHARMA.NS Aurobindo Pharma Limited
1,150.20
-0.43%
 
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,252.50
-0.19%
 
ZYDUSLIFE.NS Zydus Lifesciences Limited
974.95
-0.39%
 
DIVISLAB.NS Divi's Laboratories Limited
6,667.00
-0.86%
 
IPCALAB.NS Ipca Laboratories Limited
1,368.40
-1.06%
 
AJANTPHARM.NS Ajanta Pharma Limited
2,634.20
-3.52%